Prot # 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri: STRATIFY-2

Project: Research project

Status	Finished
Effective start/end date	7/28/10 → 7/28/16

Project Details